Annals of Pharmacotherapy · 2001 · 22 citations · 7 references
MedicineOncologyPharmacologyHepatologyHepatotoxicologyPharmaceutical ToxicologyCholestatic Liver InjuryHepatic Drug MetabolismHepatic ToxicityHepatocellular CarcinomaHepatotoxicity MechanismsLiver DiseaseAcute Hepatic FailureAdjuvant UseGlutathione S-transferase ActivityHepatotoxic MechanismsIdiosyncratic Adverse Drug ReactionsIdiosyncratic Drug ReactionsIdiosyncratic Drug ToxicityIdiosyncratic Toxicity
OBJECTIVE: To report a case of acute hepatitis resulting from the use of cyproterone acetate, an adjuvant treatment for prostate cancer. CASE SUMMARY: An 87 year-old white man, admitted to surgery for prostate cancer, received cyproterone acetate 300 mg/d orally and developed acute hepatitis, which initially was diagnosed clinically. A liver biopsy showed changes suggestive of acute cholestatic hepatitis. Cyprotorone was stopped immediately, and the patient was subsequently treated with corticosteroids. He then improved rapidly. DISCUSSION: Cyproterone acetate is thought to be well tolerated, but some authors have reported severe hepatic reactions, in particular acute hepatitis, fatal fulminant hepatic failure, and hepatocellular carcinoma. The above-mentioned hepatotoxicity represents an idiosyncratic drug reaction, probably due to the hepatomitogen action of cyproterone, causing an increase of hepatocytes expressing placental glutathione S-transferase, which are considered preneoplastic elements. CONCLUSION: This case suggests the possibility of hepatotoxicity from cyproterone.
7
A method for estimating the probability of adverse drug reactions
C. A. Naranjo, U. Busto, Edward M. Sellers et al. · Clinical Pharmacology & Therapeutics · 1981 · 11.6K citations
Annals of Internal Medicine · 1988 · 92 citations
Severe hepatitis caused by cyproterone acetate.
J Blake, A. M. Sawyerr, James Dooley et al. · Gut · 1990 · 38 citations · Full text
Medicine, Pharmacology, Toxicology +15